Philip E. Hass
- Hematology top 0.5%
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 5
- Immunology top 1%
- Complement system in diseases 9
- Immunology and Allergy top 1%
- Genetics top 2%
- Molecular Biology top 5%
- Retinal Development and Disorders 4
- Glycosylation and Glycoproteins Research 3
- Protein purification and stability 3
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Retinal Diseases and Treatments 6
- Co-authors
- Bharat B. AggarwalThomas E. EessaluBarry J. SugarmanMichael A. PalladinoH. Michael ShepardIrene S. FigariDan EatonWalter C. Darbonne
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Philip E. Hass
36 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 1.7k
- Immunology 2.1k
- Immunology and Allergy 455
- Genetics 577
- Molecular Biology 1.8k
Countries citing papers authored by Philip E. Hass
This map shows the geographic impact of Philip E. Hass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Hass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Hass more than expected).
Fields of papers citing papers by Philip E. Hass
This network shows the impact of papers produced by Philip E. Hass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Hass. The network helps show where Philip E. Hass may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip E. Hass, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 21 | |
| 2 | 2018 | 6 | |
| 3 | 2017 | 13 | |
| 4 | 2016 | 37 | |
| 5 | 2015 | 20 | |
| 6 | 2015 | 21 | |
| 7 | 2014 | 40 | |
| 8 | 2014 | 44 | |
| 9 | 2012 | 66 | |
| 10 | 2011 | 270 | |
| 11 | Targeting the Alternative Pathway of Complement in AMD With a Factor D Selective Antibody | 2010 | 2 |
| 12 | 2009 | 48 | |
| 13 | 2007 | 76 | |
| 14 | 2006 | 187 | |
| 15 | 1998 | 29 | |
| 16 | Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandbreakdown → | 1994 | 1073 |
| 17 | 1990 | 29 | |
| 18 | 1988 | 71 | |
| 19 | Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitrobreakdown → | 1985 | 1402 |
| 20 | Transferrin Receptor in Human Placental Brush Border Membranes | 1979 | 58 |
About Philip E. Hass
Philip E. Hass is a scholar working on Hematology, Ophthalmology, Immunology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 36 papers that have together received 5.6k indexed citations. Recurring topics across this work include Complement system in diseases (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Platelet Disorders and Treatments (7 papers), Retinal Diseases and Treatments (6 papers), Blood groups and transfusion (5 papers), Retinal Development and Disorders (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Protein purification and stability (3 papers). The work is most often cited by research in Hematology (1.7k citations), Immunology (2.1k citations), Immunology and Allergy (455 citations), Genetics (577 citations) and Molecular Biology (1.8k citations). Philip E. Hass has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Bharat B. Aggarwal, Thomas E. Eessalu, Barry J. Sugarman, Michael A. Palladino, H. Michael Shepard, Irene S. Figari, Dan Eaton, Walter C. Darbonne, Frédéric J. de Sauvage and David V. Goeddel. Their work appears in journals such as Blood, Journal of Biological Chemistry, Nature, mAbs and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.